ALPA LABORATORIES LTD (ALPA) financials

ALPA LABORATORIES LTD (ALPA) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 1988, Alpa Laboratories Ltd manufactures and sells Drugs and Chemicals[1]

Market Cap: ₹110Cr.
Current Price: ₹52.2
Stock P/E: 25.2
ROE: 7.90%
ROCE: 8.91%
Book Value: ₹93.4
Dividend Yield: 0.00%
52W High / Low: ₹99.8/46.0

In Jun 2026, ALPA LABORATORIES LTD (ALPA) reported sales ₹23.93 Cr and net profit ₹1.04 Cr.

Annual TTM: sales ₹111 Cr, net profit ₹4 Cr.

Shareholding: Promoters 57.19% (Sep 2026), FIIs 0.35% (Sep 2026), DIIs 0.07% (Sep 2026), Public 42.39% (Sep 2026), No. of Shareholders 17,347% (Sep 2026).

ALPA quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	24.94	26.15	39.11	19.11	25.63	29.67	31.40	23.93
Expenses	21.67	25.41	39.47	18.69	28.50	27.53	27.80	27.89
Operating Profit	3.27	0.74	-0.36	0.42	-2.87	2.14	3.60	-3.96
OPM %	13.11%	2.83%	-0.92%	2.20%	-11.20%	7.21%	11.46%	-16.55%
Other Income	6.91	8.80	3.24	11.96	3.69	0.26	-0.18	5.83
Interest	0.06	0.10	0.05	0.05	0.05	0.03	0.16	0.11
Depreciation	0.53	0.55	0.58	0.55	0.67	0.65	0.22	0.72
Profit before tax	9.59	8.89	2.25	11.78	0.10	1.72	3.04	1.04
Tax %	20.44%	0.00%	186.67%	0.00%	0.00%	-9.30%	55.59%	0.00%
Net Profit	7.63	8.89	-1.95	11.78	0.10	1.87	1.36	1.04
EPS in Rs	3.63	4.23	-0.93	5.60	0.05	0.89	0.65	0.49
Raw PDF	—	—	—	—	—	—	—	—

ALPA profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	85	97	112	93	109	110	106	111
Expenses	79	90	101	85	100	105	103	112
Operating Profit	6	8	11	8	9	5	3	-1
OPM %	7%	8%	10%	9%	8%	4.6%	3.1%	-1.0%
Other Income	0	4	11	9	14	23	16	10
Interest	0	0	0	0	0	0	0	0
Depreciation	1	1	2	1	2	2	2	2
Profit before tax	5	11	20	16	21	26	17	6
Tax %	20%	33%	28%	21%	19%	24%	10%	—
Net Profit	4	7	14	13	17	20	15	4
EPS in Rs	1.94	3.45	6.72	6.00	7.98	9.35	7.11	2.08
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	—

ALPA balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	21	21	21	21	21	21	21	21
Reserves	85	89	96	111	124	141	161	176
Borrowings	2	0	0	6	3	5	0	2
Other Liabilities	21	21	33	28	30	25	51	53
Total Liabilities	129	131	150	165	178	192	233	251
Fixed Assets	6	6	7	9	7	11	21	20
CWIP	0	1	2	0	0	0	0	0
Investments	59	68	62	86	90	109	129	153
Other Assets	64	56	80	70	81	72	83	78
Total Assets	129	131	150	165	178	192	233	251

ALPA cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	-1	18	-1	2	10	4	18	10
Cash from Investing Activity	-15	-11	6	-16	1	-13	-12	-12
Cash from Financing Activity	-5	-1	-0	5	-3	2	-5	1
Net Cash Flow	-20	5	4	-8	8	-7	0	-0
Free Cash Flow	-2	15	-4	0	9	-3	7	6
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	116%	316%	18%	54%	171%	85%	445%	388%

ALPA shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	57.29%	57.29%	57.29%	57.29%	57.29%	57.19%	57.19%	57.19%
FIIs	0.35%	0.40%	0.36%	0.35%	0.36%	0.38%	0.35%	0.35%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.07%	0.07%
Public	42.34%	42.30%	42.34%	42.36%	42.35%	42.43%	42.38%	42.39%
No. of Shareholders	19,206	18,872	18,851	18,542	18,236	17,900	17,643	17,347

ALPA key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	141	105	133	124	186	138	155	141
Inventory Days	105	90	102	81	84	73	92	73
Days Payable	99	98	152	78	100	63	97	98
Cash Conversion Cycle	148	97	83	127	170	149	150	116
Working Capital Days	189	121	137	124	150	132	108	73
ROCE %	4%	7%	7%	9%	11%	14%	15%	9%

ALPAUpdated 21 Oct 2026, 6:07

Alpa Laboratories Ltd

ALPAUpdated 21 Oct 2026, 6:07

Market Cap

₹110Cr.

Current Price

₹52.2

High / Low

₹99.8/46.0

Stock P/E

25.2

ROE7.90%

ROCE8.91%

Book Value₹93.4

Face Value₹10.0

Dividend Yield0.00%

About

Incorporated in 1988, Alpa Laboratories Ltd manufactures and sells Drugs and Chemicals[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	25.43	0.02	26.58	4.47	0.28	3.02	0	3.03	1.44
Sep 2023	32.39	0.04	29.07	2.95	0.49	5.74	0	5.74	2.73
Dec 2023	27.31	0.03	24.85	3.55	0.66	5.32	14.85	4.53	2.15
Mar 2024	23.61	0.3	20.1	3.97	0.52	6.66	46.7	3.55	1.69
Jun 2024	21.44	0.05	20.9	5.18	0.54	5.13	0	5.12	2.43
Sep 2024	24.94	0.06	21.67	6.91	0.53	9.59	20.44	7.63	3.63
Dec 2024	26.15	0.1	25.41	8.8	0.55	8.89	0	8.89	4.23
Mar 2025	39.11	0.05	39.47	3.24	0.58	2.25	186.67	-1.95	-0.93
Jun 2025	19.11	0.05	18.69	11.96	0.55	11.78	0	11.78	5.6
Sep 2025	25.63	0.05	28.5	3.69	0.67	0.1	0	0.1	0.05
Dec 2025	29.67	0.03	27.53	0.26	0.65	1.72	-9.3	1.87	0.89
Mar 2026	31.4	0.16	27.8	-0.18	0.22	3.04	55.59	1.36	0.65
Jun 2026	23.93	0.11	27.89	5.83	0.72	1.04	0	1.04	0.49

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	57	2	54	2	6	-3	-48	-1	-0.67
Mar 2016	53	1	47	6	1	11	27	8	3.68
Mar 2017	63	2	56	4	1	9	34	6	2.85
Mar 2018	62	1	57	5	1	7	27	5	2.27
Mar 2019	77	1	76	5	1	5	36	3	1.4
Mar 2020	85	0	79	0	1	5	20	4	1.94
Mar 2021	97	0	90	4	1	11	33	7	3.45
Mar 2022	112	0	101	11	2	20	28	14	6.72
Mar 2023	93	0	85	9	1	16	21	13	6
Mar 2024	109	0	100	14	2	21	19	17	7.98
Mar 2025	110	0	105	23	2	26	24	20	9.35
Mar 2026	106	0	103	16	2	17	10	15	7.11
TTM	111	0	112	10	2	6	—	4	2.08

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	57.19%
FIIs	0.35%
DIIs	0.07%
Public	42.39%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	57.29%	0.95%	0%	41.74%
Mar 2024	57.29%	0.5%	0%	42.21%
Jun 2024	57.29%	0.36%	0%	42.35%
Sep 2024	57.29%	0.74%	0%	41.97%
Dec 2024	57.29%	0.35%	0%	42.34%
Mar 2025	57.29%	0.4%	0%	42.3%
Jun 2025	57.29%	0.36%	0%	42.34%
Sep 2025	57.29%	0.35%	0%	42.36%
Dec 2025	57.29%	0.36%	0%	42.35%
Mar 2026	57.19%	0.38%	0%	42.43%
Jun 2026	57.19%	0.35%	0.07%	42.38%
Sep 2026	57.19%	0.35%	0.07%	42.39%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	21	66	29	13	128	5	0	10	113	128
Mar 2016	21	73	24	27	145	5	0	22	118	145
Mar 2017	21	77	11	20	129	5	0	23	100	129
Mar 2018	21	82	6	17	127	6	0	41	79	127
Mar 2019	21	85	2	21	129	6	0	59	64	129
Mar 2020	21	89	0	21	131	6	1	68	56	131
Mar 2021	21	96	0	33	150	7	2	62	80	150
Mar 2022	21	111	6	28	165	9	0	86	70	165
Mar 2023	21	124	3	30	178	7	0	90	81	178
Mar 2024	21	141	5	25	192	11	0	109	72	192
Mar 2025	21	161	0	51	233	21	0	129	83	233
Mar 2026	21	176	2	53	251	20	0	153	78	251

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	-2	37	7	42
Mar 2016	-25	-7	-6	-37
Mar 2017	-8	1	-2	-9
Mar 2018	-7	-16	4	-19
Mar 2019	-1	-15	-5	-20
Mar 2020	18	-11	-1	5
Mar 2021	-1	6	0	4
Mar 2022	2	-16	5	-8
Mar 2023	10	1	-3	8
Mar 2024	4	-13	2	-7
Mar 2025	18	-12	-5	0
Mar 2026	10	-12	1	0

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	156	234	169	151	141	105	133	124	186	138	155	141
Inventory Days	76	196	131	140	105	90	102	81	84	73	92	73
Days Payable	91	244	140	130	99	98	152	78	100	63	97	98
Cash Conversion Cycle	141	187	160	161	148	97	83	127	170	149	150	116
Working Capital Days	-4	224	197	204	189	121	137	124	150	132	108	73
ROCE %	0%	10%	11%	7%	4%	7%	7%	9%	11%	14%	15%	9%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of ALPA LABORATORIES LTD (ALPA)?

The reported market capitalisation for ALPA LABORATORIES LTD (ALPA) is ₹110Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of ALPA?

The current price shown for ALPA LABORATORIES LTD (ALPA) on Fincrux is ₹52.2 with a 52-week high/low of ₹99.8/46.0.

What is the P/E ratio of ALPA LABORATORIES LTD (ALPA)?

The stock P/E for ALPA LABORATORIES LTD (ALPA) is 25.2 on Fincrux, with ROE at 7.90% and ROCE at 8.91%.

What were ALPA latest quarterly results?

For Jun 2026, ALPA LABORATORIES LTD (ALPA) reported sales ₹23.93 Cr and net profit ₹1.04 Cr (figures in ₹ crore unless noted).

What are ALPA annual sales and net profit?

For TTM, ALPA LABORATORIES LTD (ALPA) shows sales of ₹111 Cr and net profit of ₹4 Cr on the Fincrux profit & loss statement.

Who owns ALPA LABORATORIES LTD (ALPA)?

Latest shareholding for ALPA LABORATORIES LTD (ALPA) on Fincrux: Promoters 57.19% (Sep 2026), FIIs 0.35% (Sep 2026), DIIs 0.07% (Sep 2026), Public 42.39% (Sep 2026), No. of Shareholders 17,347% (Sep 2026).

Where can I find ALPA LABORATORIES LTD (ALPA) financials?

ALPA LABORATORIES LTD (ALPA) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show ALPA balance sheet and cash flow?

Yes. The ALPA LABORATORIES LTD (ALPA) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 21 October 2026 at 6:07